The Fos-related antigen Fra-1 is an activator of bone matrix formation

Area of Science:

• Molecular Biology
• Developmental Biology
• Bone Biology

Background:

• Ectopic expression of transcription factor Fra-1 in mice causes osteosclerosis (increased bone mass).
• Conventional Fra-1 knockout mice are not viable due to placental defects, hindering loss-of-function studies.
• The molecular mechanisms underlying Fra-1's role in bone regulation remain unclear.

Purpose of the Study:

• To investigate the function of Fra-1 in bone mass regulation using a conditional knockout approach.
• To elucidate the molecular basis of Fra-1's impact on bone development and homeostasis.

Main Methods:

• Generated viable Fra-1 knockout mice (fra-1(delta/delta)) by rescuing embryonic lethality through targeted deletion in the embryo, not the placenta.
• Analyzed bone phenotype, osteoclast numbers, and expression of bone matrix components in fra-1(delta/delta) mice.
• Assessed the effect of Fra-1 on matrix Gla protein gene expression.

Main Results:

• Conditional knockout of Fra-1 in mice leads to osteopenia (low bone mass).
• fra-1(delta/delta) mice exhibit normal osteoclasts but reduced expression of osteocalcin, collagen1a2, and matrix Gla protein in long bones.
• Matrix Gla protein gene expression is significantly upregulated in the long bones of Fra-1 transgenic mice, suggesting it is a direct target.

Conclusions:

• Fra-1 plays a critical role in regulating bone mass.
• Fra-1 influences bone mass primarily through regulating bone matrix production by osteoblasts and chondrocytes.
• Targeting Fra-1 may offer new therapeutic strategies for bone disorders.